Benzimidazolone derivatives with central dopaminergic activity
US5883094A · kind A · utility
25Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 1997 |
| Grant date | Mar 16, 1999 |
| Priority date | — |
| Expiry date | Mar 11, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to novel, pharmaceutically active benzimidazolone derivatives of the formula ##STR1## wherein the dashed line, R.sup.0 through R.sup.6 and X.sup.1 through X.sup.3 are defined as in the specification. These compounds exhibit central dopaminergic activity and are u in the treatment of CNS disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.